InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Loh Evan. Officer active across 2 companies, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 8 disclosures have been logged. Total volume traded: €109k. The latest transaction was filed on 15 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
0236,250 shares0
Common Stock
SEC:0000904454-22-000268:0·
06,000 shares0
Common Stock
SEC:0001140361-22-009258:0·
€54,63713,983 shares@ €3.9074100.0% of flow
Common Stock
SEC:0000904454-21-000840·
€54,63713,983 shares@ €3.907450.0% of flow
Common Stock
SEC:0000904454-21-000840:0·
075,000 shares0
Common Stock
SEC:0000904454-21-000630·
075,000 shares0
Common Stock
SEC:0000904454-21-000630:0·
091,636 shares0
Common Stock
SEC:0000904454-21-000512·
091,636 shares0
Common Stock
SEC:0000904454-21-000512:0·
8 of 8 declarations
About Loh Evan
Loh Evan is a director at Paratek Pharmaceuticals, Inc. and also involved with Eiger BioPharmaceuticals, Inc.
